Get started
KRUNG THAI BANK PUBLIC CO LTDKRUNG THAI BANK PUBLIC CO LTDKRUNG THAI BANK PUBLIC CO LTD

KRUNG THAI BANK PUBLIC CO LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

NOVOB80 chart


Full chart

Key facts today


Novo Nordisk's shares fell over 7% due to positive trial results from Eli Lilly's obesity drug, orforglipron, amid rising competition in the GLP-1 market.
Novo Nordisk seeks approval for a higher dose of its oral weight-loss pill, linked to its diabetes drugs, Wegovy and Ozempic, while also developing another oral weight-loss treatment.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪9.51 T‬ THB
Dividend yield (indicated)
1.33%
Price to earnings Ratio (TTM)
0.02
Basic EPS (TTM)
107.92 THB
Net income (FY)
‪480.63 B‬ THB
Revenue (FY)
‪1.38 T‬ THB
Shares float
‪3.16 B‬
Beta (1Y)
−0.57

About NOVO NORDISK B A/S


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Lars Fruergaard Jørgensen
Website
novonordisk.com
Headquarters
Bagsværd
Founded
1931
ISIN
TH0150122503
FIGI
BBG01Q6L1RY0
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NOVOB80 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NOVOB80 highest yielding bonds


N
XS282046075
NOVO NO.F.NL 24/34 MTN
Yield to maturity
3.22%
Maturity date
May 21, 2034
N
XS282045567
NOVO NO.F.NL 24/31 MTN
Yield to maturity
2.81%
Maturity date
Jan 21, 2031
XS244124704
NOVO NO.F.NL 22/30MTN
Yield to maturity
2.76%
Maturity date
Mar 31, 2030
N
XS282045460
NOVO NO.F.NL 24/29 MTN
Yield to maturity
2.49%
Maturity date
Jan 21, 2029
XS234803042
NOVO NO.F.NL 21/28
Yield to maturity
2.47%
Maturity date
Jun 4, 2028
N
XS282044994
NOVO NO.F.NL 24/26 MTN
Yield to maturity
2.46%
Maturity date
May 21, 2026
XS244933017
NOVO NO.F.NL 22/27MTN
Yield to maturity
2.35%
Maturity date
Sep 30, 2027

See all NOVOB80 bonds 

Sparks


Curated watchlists where NOVOB80 is featured.

See all sparks 


Check out other big names from the same industry as NOVOB80.